A carregar...

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC

Abstract A high rate of thrombotic complications, such as pulmonary embolism, has been linked to mortality in COVID-19, and appropriate treatment of thrombosis is important for lifesaving. Although heparin is frequently used to treat thrombotic pathology in COVID-19, pulmonary embolism is still seen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hidesaku Asakura, Haruhiko Ogawa
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-09-01
Colecção:Journal of Intensive Care
Assuntos:
Acesso em linha:http://link.springer.com/article/10.1186/s40560-020-00491-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!